Know your World in Just 60 Words!
Read news in 1 minute
Hot Topics
Select the content to hear the Audio

Added on : 2022-08-16 08:48:15

Serum Institute of India's (SII) CEO Adar Poonawalla has said that a COVID-19 vaccine that specifically targets the Omicron variant is expected in India in the next six months, reports said on Monday. SII is the world's biggest vaccine maker and it manufactures the Oxford/AstraZeneca COVID-19 vaccine, sold as Covishield in India.

Covid 19 Update


Good News




Copyright © 2019 Newz Viewz | Created by Communicators and Developed by Seawind Solution Pvt. Ltd.